MAPP BIOPHARMACEUTICAL, INC.

Company Information
Address 6160 LUSK BLVD STE 105
SAN DIEGO, CA, 92121-2740

http://www.mappbio.com

Information

DUNS: 137551797

# of Employees: 40


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of a monoclonal immunoprotectant for ricin

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The National Institutes of Health has deemed the development of therapeutics against potential bioterrorism agents as a national research priority. There is a part ...

    SBIRPhase I2010Department of Health and Human Services
  2. An Immunoprotectant for Marburg Virus

    Amount: $524,876.00

    DESCRIPTION (provided by applicant): Mortality rates associated with Marburg virus (MARV) outbreaks range from 23% to over 90%. MARV is included by the Centers for Disease Control and Prevention as am ...

    SBIRPhase I2009Department of Health and Human Services
  3. Monoclonal Antibody SEB Immunoprotectant

    Amount: $599,821.00

    DESCRIPTION (provided by applicant): Staphylococcal enterotoxin B (SEB; Category B agent), a toxin that commonly causes classic food poisoning and can cause a nonmenstrual toxic shock syndrome (TSS), ...

    SBIRPhase I2008Department of Health and Human Services
  4. Monoclonal Antibodies for Alzheimer's Immunotherapy

    Amount: $2,815,180.00

    DESCRIPTION (provided by applicant): The primary focus of this Phase II proposal is development of a product against Alzheimer's disease (AD). AD is an increasingly important cause of morbidity and mo ...

    SBIRPhase II2008Department of Health and Human Services
  5. Development of a C. difficile Monoclonal-based Product

    Amount: $997,007.00

    DESCRIPTION (provided by applicant): According to the CDC, each year more than two million U.S. hospital patients contract nosocomial infections, and some 80,000 of them die as a result (Federal Regis ...

    SBIRPhase II2007Department of Health and Human Services
  6. A Monoclonal Antibody Immunoprotectant for Ebola Virus

    Amount: $270,810.00

    DESCRIPTION (provided by applicant): The primary focus of this proposal is development of a product for protection against Ebola virus (Category A agent). Through collaboration between Mapp Biopharmac ...

    SBIRPhase I2007Department of Health and Human Services
  7. A HUMAN MONOCLONAL COCKTAIL FOR RSV IMMUNOTHERAPY

    Amount: $570,972.00

    DESCRIPTION (provided by applicant): The central goal of this application is to develop a combination product comprising two fully human monoclonal antibodies (mAbs) produced in plants for the prevent ...

    STTRPhase I2006Department of Health and Human Services
  8. MONOCLONAL ANTIBODIES FOR ALZHEIMER'S IMMUNOTHERAPY

    Amount: $445,868.00

    DESCRIPTION (PROVIDED BY APPLICANT): Transgenic mice administered anti-amyloid peptide antibodies, acutely or subchronically, show markedly improved learning and memory performance. Recent reports sug ...

    SBIRPhase I2005Department of Health and Human Services
  9. ANTI-C. DIFFICILE HUMAN MONOCLONALS FOR IMMUNOTHERAPY

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Clostridium difficile associated disease (CDAD) is an important cause of morbidity in hospital and nursing home patients, and is being increasingly recognized as ...

    SBIRPhase I2004Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government